Redcare Pharmacy N.V.

Redcare Pharmacy’s Annual General Meeting 2024 approved all agenda items. Dirk Brüse and Lode Fastré new members of the Managing Board.

Strong start of the year for Redcare Pharmacy, double-digit sales growth continues.

Successful completion of a record year for Redcare Pharmacy: growth 49%, adj. EBITDA margin up 3.7pp to 3%; guidance achieved in all its elements.

Seamless transition for continuity and stability: Redcare Pharmacy with internal succession plan for Stephan Weber (CCO) and Marc Fischer (CIO).

Redcare Pharmacy with internal succession plan due to the early departure of CCO Stephan Weber and CIO Marc Fischer at the Annual General Meeting on 17 April 2024.

Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Another successful fast-growth quarter for Redcare Pharmacy, completing full year 2023 at the very upper end of its guidance.

Redcare Pharmacy: continued very fast growth combined with major margin lift; adj. EBITDA 3.2% in Q3, vs. 0.4% last year.

Redcare Pharmacy continues to successfully grow fast in all its markets.

Redcare Pharmacy N.V.: Jasper Eenhorst, Sale of shares resulting from the exercise of a stock option plan.

Redcare Pharmacy N.V.: Jasper Eenhorst, Acquisition through exercise of stock options

Redcare Pharmacy Q2 2023: While fast sales growth continues unabated at 46%, adj. EBITDA margin improved 5.3pp year over year to 3.2%. Company raises full-year guidance.

Very successful quarter for Redcare Pharmacy N.V. with a further acceleration in sales growth.

Welcome, Redcare Pharmacy: Official ticker-symbol change on the Frankfurt Stock Exchange and the new corporate site launch today.

SHOP APOTHEKE EUROPE PROMOTED TO THE MDAX.

Redcare Pharmacy N.V. (formerly SHOP APOTHEKE EUROPE N.V.): Termination of voting pool agreement.

SHOP APOTHEKE EUROPE N.V.: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Joint Venture Approved: SHOP APOTHEKE EUROPE and Galenica Create the Leading Online Pharmacy in Switzerland.

SHOP APOTHEKE EUROPE and GALENICA: Antitrust clearances for joint venture granted

SHOP APOTHEKE EUROPE N.V.: Marc Michael Fischer , sell

SHOP APOTHEKE EUROPE: STRONG Q1 WITH 22% SALES GROWTH AND EBITDA MARGIN IN UPPER PART OF FULL-YEAR GUIDANCE.

Successful Outcome for SHOP APOTHEKE EUROPE’s Annual General Meeting 2023: Approval of New CEO and Change of Corporate Name.

SHOP APOTHEKE EUROPE: VERY STRONG START TO YEAR, FASTEST GROWTH SINCE EARLY 2021.

SHOP APOTHEKE EUROPE N.V.: Theresa Margarete Holler , sell

SHOP APOTHEKE EUROPE and GALENICA enter into a strategic partnership and jointly establish the leading online pharmacy in Switzerland.

​​​​​​​SHOP APOTHEKE EUROPE N.V. and GALENICA AG enter into strategic partnership and establish a joint venture for the Swiss business; execution of capital increase.

SHOP APOTHEKE EUROPE N.V. PUBLISHES CONVOCATION FOR ANNUAL GENERAL MEETING OF SHAREHOLDERS 2023

SHOP APOTHEKE EUROPE TO APPOINT OLAF HEINRICH AS NEW CEO.

SHOP APOTHEKE EUROPE N.V.: Olaf Heinrich shall become the new CEO